Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin

References

• KarimiMYavarianMAfrasiabiAPrevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian JewsArch Med Res200839221221418164966
   PubMed Web of Science ®Google Scholar
• SalehiRFisherCABignellPAIdentification of three novel mutations [-41 (A > C), codon 24 (-G), and IVS-I-109 (-T)], in a study of beta-thalassemia alleles in the Isfahan region of IranHemoglobin201034111512020113296
   PubMed Web of Science ®Google Scholar
• Derakhshandeh-PeykarPAkhavan-NiakiHTamaddoniADistribution of beta-thalassemia mutations in the northern provinces of IranHemoglobin200731335135617654072
   PubMed Web of Science ®Google Scholar
• StraussBSGenetic counseling for thalassemia in the Islamic Republic of IranPerspect Biol Med200952336437619684371
   PubMed Web of Science ®Google Scholar
• GalanelloROrigaRBeta-thalassemiaOrphanet J Rare Dis201051120492708
   PubMed Web of Science ®Google Scholar
• AlterMJEpidemiology of hepatitis CHepatology1997266265
   PubMed Web of Science ®Google Scholar
• RezvanHAbolghassemiHKafiabadSATransfusion-transmitted infections among multitransfused patients in Iran: a reviewTransfus Med200717642543318067646
   PubMed Web of Science ®Google Scholar
• AngelucciEAntibodies to hepatitis C virus in thalassemiaHaematologica1994793533557528705
   PubMed Web of Science ®Google Scholar
• AlavianSMTabatabaeiSVLankaraniKBEpidemiology of HCV infection among thalassemia patients in Eastern Mediterranean countries: a quantitative review of literatureIranian Red Crescent Medical Journal2010124365376
   Web of Science ®Google Scholar
• PratiDMaggioniMMilaniSClinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 casesHaematologica200489101179118615477201
   PubMed Web of Science ®Google Scholar
• ArdalanFAOsqueiMRToosiMNIrvanlooGSynergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional studyBMC Gastroenterol200441715307893
   PubMed Web of Science ®Google Scholar
• AngelucciEMurettoPNicolucciAEffects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantationBlood20021001172112070002
   PubMed Web of Science ®Google Scholar
• Di MarcoVCapraMAngelucciEManagement of chronic viral hepatitis in patients with thalassemia: an international panel’s recommendationsBlood2010615 [Epub ahead of print].
   Web of Science ®Google Scholar
• CohenARGalanelloRPennellDJThalassemiaHematology Am Soc Hematol Educ Program2004143415561674
   PubMedGoogle Scholar
• HernándezNMesciaGPollioCEffectiveness of pegylated interferon alfa 2a and ribavirin for chronic hepatitis C in clinical practiceActa Gastroenterol Latinoam201040211712120645558
   PubMedGoogle Scholar
• NIH Consensus Statement on Management of Hepatitis C: 2002NIH Consens State Sci Statements2002193146
   Google Scholar
• YuMLChuangWLTreatment of chronic hepatitis C in Asia: when East meets WestJ Gastroenterol Hepatol200924333634519335784
   PubMed Web of Science ®Google Scholar
• VeldtBJHeathcoteEJWedemeyerHSustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosisAnn Intern Med20071471067768418025443
   PubMed Web of Science ®Google Scholar
• WeltmanMDBrotodihardjoACreweEBCoinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatmentJ Viral Hepat1995239457493293
   PubMed Web of Science ®Google Scholar
• KasererKFiedlerRSteindlPLiver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis CHistopathology1998324544619639122
   PubMed Web of Science ®Google Scholar
• AlbertiAWhat are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?Liver Int2009291151819207961
   PubMed Web of Science ®Google Scholar
• El-ZayadiARHepatitis C comorbidities affecting the course and response to therapyWorld J Gastroenterol200915404993499919859990
   PubMed Web of Science ®Google Scholar
• TsaiNCZuckermanEHanSHEffect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapyAm J Gastroenterol19979210183118349382046
   PubMed Web of Science ®Google Scholar
• BurtMJCooksleyWGThe influence of iron on chronic hepatitis CJ Gastroenterol Hepatol19981333303339570251
   PubMed Web of Science ®Google Scholar
• DistanteSBjøroKHellumKBRaised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infectionLiver200222326927512100578
   PubMedGoogle Scholar
• LebrayPZylberbergHHueSInfluence of HFE gene polymorphism on the progression and treatment of chronic hepatitis CJ Viral Hepat200411217518214996353
   PubMed Web of Science ®Google Scholar
• ShedlofskySIRole of iron in the natural history and clinical course of hepatitis C diseaseHepatogastroenterology199845203493559638405
   PubMedGoogle Scholar
• OrtizVOlasoVLópez ViedmaBThe effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot studyGastroenterol Hepatol199922312212610228321
   PubMedGoogle Scholar
• HerreraJLIron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapyAm J Gastroenterol199994123571357510606321
   PubMed Web of Science ®Google Scholar
• FargionSFracanzaniALRossiniAIron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized studyAm J Gastroenterol20029751204121012014729
   PubMed Web of Science ®Google Scholar
• ErhardtAHauckKHäussingerDIron as comorbid factor in chronic hepatitis CMed Klin (Munich)2003981268569114685669
   PubMedGoogle Scholar
• AlavianSMMiriSMKeshvariMDistribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemiaTransfusion200949102195219919538541
   PubMed Web of Science ®Google Scholar
• PipernoASampietroMD’AlbaRIron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis CLiver19961642482548877995
   PubMedGoogle Scholar
• Martín-VivaldiRNoguerasFGonzálezAResponse of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolismRev Esp Enferm Dig19978975235309265838
   PubMed Web of Science ®Google Scholar
• FargionSFracanzaniALSampietroMLiver iron influences the response to interferon alpha therapy in chronic hepatitis CEur J Gastroenterol Hepatol1997954975039187884
   PubMed Web of Science ®Google Scholar
• SikorskaKStalkePIzycka-SwieszewskaEThe role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis CMed Sci Monit2010163137143
   Web of Science ®Google Scholar
• Van ThielDHFriedlanderLFagiuoliSResponse to interferon alpha therapy is influenced by the iron content of the liverJ Hepatol19942034104158014455
   PubMed Web of Science ®Google Scholar
• OlynykJKReddyKRDi BisceglieAMHepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis CGastroenterology19951084110411097698578
   PubMed Web of Science ®Google Scholar
• SievertWPiankoSWarnerSHepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia majorAm J Gastroenterol200297498298712003436
   PubMed Web of Science ®Google Scholar
• PiankoSMcHutchisonJGGordonSCHepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infectionJ Interferon Cytokine Res200222448348912034031
   PubMed Web of Science ®Google Scholar
• RulyakSJEngSCPatelKRelationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirinAm J Gastroenterol2005100233233715667490
   PubMed Web of Science ®Google Scholar
• Pereira PdaSSilvaISUeharaSNChronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapyRev Inst Med Trop Sao Paulo200951633133620209268
   PubMed Web of Science ®Google Scholar
• FujitaNSugimotoRUrawaNHepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis CJ Gastroenterol Hepatol200722111886189317914965
   PubMed Web of Science ®Google Scholar
• LinTJLiaoLYLinCLHepatic iron influences responses to combination therapy with peginterferon alfa and ribavirin in chronic hepatitis CHepatogastroenterology200855851412141518795701
   PubMedGoogle Scholar
• BertinoGArdiriAMBoemiPMHepatic iron, iron depletion and response to therapy with peg-Interferon and Ribavirin in chronic hepatitis C. Pilot studyClin Ther20071585391395
   Google Scholar
• SouzaRMFreitasLALyraACEffect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infectionBraz J Med Biol Res2006391798316400467
   PubMed Web of Science ®Google Scholar
• De GalocsyCKaufmanLTomasovicSHepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1Acta Gastroenterol Belg201073222923420690561
   PubMed Web of Science ®Google Scholar
• AlavianSMTabatabaeiSVTreatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysisJ Viral Hepat201017423624419638104
   PubMed Web of Science ®Google Scholar
• JurczykKKarpińskaEWawrzynowicz-SyczewskaMState of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirinHepatogastroenterology20085582–8355756118613407
   PubMedGoogle Scholar
• TalianiGGemignaniGFerrariCPegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patientsGastroenterology200613041098110616618404
   PubMed Web of Science ®Google Scholar